Senti Biosciences Holdings SNTI Income Statement (2021-2025)

NASDAQ SNTI
$0.44 -0.02 (-4.35%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.78M1.10M0.32M1.10M1.36M1.52M0.06M1.29M0.69M0.34M
Operating items
Research & Development (Quarter) 5.24M5.41M6.41M7.60M9.25M6.52M7.04M7.06M6.88M9.09M9.12M8.78M9.15M8.65M7.77M9.28M10.03M10.52M7.76M
Selling, General & Administrative (Quarter) 4.55M7.12M5.27M5.26M13.88M9.99M9.82M9.19M9.25M9.43M9.30M7.52M4.21M6.56M8.08M7.12M6.77M6.43M5.85M
Other Operating Expenses (Quarter) 0.00M0.29M0.34M0.03M1.63M-0.40M
Operating Expenses (Quarter) 0.00M9.79M12.53M11.68M12.86M23.13M16.51M16.85M16.25M16.12M44.21M18.70M16.30M13.36M15.21M16.17M16.40M16.80M16.95M18.66M
Operating Income (Quarter) -0.00M-9.00M-11.42M-3.87M-11.76M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.21M-16.17M-16.40M-16.80M-16.95M-18.64M
EBIT (Quarter) -0.00M-9.00M-11.42M-3.87M-11.76M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.21M-16.17M-16.40M-16.80M-16.95M-18.64M
Non-operating items
Interest & Investment Income (Quarter) 965.000.00M0.01M0.02M
Other Non Operating Income (Quarter) 0.11M-0.05M1.29M0.00M-0.00M-0.01M-0.00M-0.01M-0.01M0.01M-0.01M0.21M0.18M0.20M0.20M0.19M
Non Operating Income (Quarter) -3.01M0.02M-14.88M-0.05M10.22M0.45M11.85M1.11M0.94M7.26M0.43M4.19M2.15M-13.65M15.56M2.29M0.27M-1.18M0.10M
Net income details
EBT (Quarter) -0.00M-9.00M-11.42M-33.57M-11.73M-82.14M-74.42M-58.84M-72.87M-71.34M-98.26M-79.95M-67.11M-62.37M-27.79M-97.88M-21.55M-58.45M-26.59M-117.36M
Profit After Tax (Quarter) -21.00M-12.01M-11.41M-3.86M-11.81M-11.55M-16.64M-49.66M-18.72M-18.70M-14.92M-71.06M-12.11M-11.20M-28.87M-0.62M-14.11M-14.73M-18.13M-14.47M
Income from Non-Controlling Interests (Quarter) 0.00M0.00M-0.00M1.46M1.59M6.40M1.71M1.60M
Income from Continuing Operations (Quarter) -0.00M-9.00M-11.42M-33.57M-11.73M-82.14M-74.42M-58.84M-72.87M-71.34M-98.26M-79.95M-67.11M-62.37M-27.79M-97.88M-21.55M-58.45M-26.59M-117.36M
Consolidated Net Income (Quarter) -0.00M-9.00M-11.42M-33.57M-11.73M-82.14M-2.34M-8.54M-4.87M-4.45M21.69M-0.03M-21.55M-58.45M-26.59M-117.36M
Income towards Parent Company (Quarter) -0.00M-9.00M-11.42M-33.57M-11.73M-82.14M-2.34M-8.54M-4.87M-4.45M21.69M-0.03M-21.55M-58.45M-26.59M-117.36M
Net Income towards Common Stockholders (Quarter) -0.00M-9.00M-11.42M-33.57M-11.73M-82.14M-2.34M-8.54M-4.87M-4.45M21.69M-0.03M-12.11M-11.20M-28.87M-14.11M-14.73M-18.13M-117.36M
Additional items
EPS (Basic) (Quarter) 0.00-4.11-3.88-115.26-4.95-61.09-0.54-3.27-1.11-1.004.88-0.01-2.65-2.45-6.31-1.41-0.56-0.69-5.22
EPS (Diluted) (Quarter) -30.92-39.03-115.26-37.00-61.09-0.54-3.27-1.11-1.004.88-0.01-2.65-2.45-6.31-1.41-0.56-0.69-5.22
Shares Outstanding (Quarter) 0.50M2.19M2.95M0.29M2.37M1.34M4.34M2.61M4.41M4.43M4.45M4.44M4.57M4.57M4.58M4.60M10.01M26.08M26.23M22.48M
Shares Outstanding (Diluted) (Quarter) 0.29M0.29M0.29M0.32M1.34M4.34M2.61M4.41M4.43M4.45M4.44M4.57M4.57M4.58M4.60M10.01M26.08M26.23M22.48M
Shares Outstanding (Entity) (Quarter) 0.57M2.37M2.37M0.29M2.37M1.34M4.36M2.61M4.41M4.45M4.45M4.57M4.57M4.57M4.59M4.83M10.01M26.16M26.29M22.48M
EBITDA (Quarter) -0.00M-9.00M-11.42M-3.87M-11.76M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.21M-16.17M-16.40M-16.80M-16.95M-18.64M
Interest Expenses (Quarter) 29.71M60.37M59.67M42.05M57.90M56.16M54.38M61.25M50.81M49.01M12.58M81.71M5.15M41.65M9.64M98.72M